LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Home・Elenco Azioni・Lyell Immunopharma Inc

Lyell Immunopharma Inc

Chiusa

23.93 3.06

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

21.78

Massimo

23.93

Metriche Chiave
By Trading Economics
Entrata	3.8M -39M
Vendite	7K 15K
EPS	-2.13
Margine di Profitto	-258,973.333
Dipendenti	300
EBITDA	6.3M -36M

Raccomandazioni
By TipRanks
Raccomandazioni	Neutrale
Previsioni per 12 mesi	+18.26% upside

Dividendi
By Dow Jones
Utili prossimi	9 mar 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	172M 512M
Apertura precedente	20.87
Chiusura precedente	23.93

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

0.4217 / 0.4691 Supporto e resistenza

Lyell Immunopharma Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

4 mar 2026, 23:39 UTC

Azioni calde

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mar 2026, 23:20 UTC

Utili

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mar 2026, 21:43 UTC

Utili

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mar 2026, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mar 2026, 23:33 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mar 2026, 23:24 UTC

Discorsi di Mercato

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mar 2026, 22:30 UTC

Utili

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mar 2026, 22:30 UTC

Utili

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mar 2026, 22:30 UTC

Utili

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mar 2026, 22:13 UTC

Utili

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mar 2026, 22:13 UTC

Utili

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mar 2026, 22:13 UTC

Utili

Vermilion Energy 4Q EPS C$2.86 >VET

4 mar 2026, 22:04 UTC

Discorsi di Mercato

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mar 2026, 21:53 UTC

Utili

Lithium Americas 4Q Rev $66.8M >LAC

4 mar 2026, 21:53 UTC

Utili

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mar 2026, 21:52 UTC

Utili

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:50 UTC

Utili

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mar 2026, 21:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

4 mar 2026, 21:48 UTC

Utili

Webull 4Q Rev $165.2M >BULL

4 mar 2026, 21:48 UTC

Utili

Webull 4Q EPS 1c >BULL

4 mar 2026, 21:45 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

4 mar 2026, 21:45 UTC

Discorsi di Mercato

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mar 2026, 21:40 UTC

Utili

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:36 UTC

Principali Notizie su Eventi

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mar 2026, 21:27 UTC

Utili

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:17 UTC

Discorsi di Mercato

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mar 2026, 21:16 UTC

Utili

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mar 2026, 21:15 UTC

Utili

Broadcom 1Q EPS $1.50 >AVGO

4 mar 2026, 21:15 UTC

Utili

Broadcom 1Q Net $7.35B >AVGO

4 mar 2026, 21:15 UTC

Utili

Broadcom 1Q Rev $19.31B >AVGO

Confronto tra pari

Modifica del prezzo

Lyell Immunopharma Inc Previsione

Obiettivo di Prezzo

By TipRanks

18.26% in crescita

Previsioni per 12 mesi

Media 28.5 USD 18.26%

Alto 45 USD

Basso 12 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Lyell Immunopharma Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

2 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 2 che hanno fornito valutazioni azionarie a Lyell Immunopharma Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

0.4217 / 0.4691Supporto e resistenza

Recent bearish events outweigh bullish events.

There is one bearish event.

There are no events.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Altri titoli del settore

LLY

Eli Lilly and Co.

1,003.75

↓-0.1%

JNJ

Johnson and Johnson

245.32

↓-0.54%

ABBV

AbbVie Inc

235.99

↑ +1.04%

NVS

Novartis AG

165.01

↑ +0.53%

AZN

AstraZeneca PLC

201.13

↑ +0.17%

Lyell Immunopharma Inc

Panoramica

Variazione del prezzo dell'azione

Metriche Chiave

Raccomandazioni

Dividendi

Statistiche di mercato

Punteggio Tecnico

Lyell Immunopharma Inc Grafico

Notizie correlate

Confronto tra pari

Lyell Immunopharma Inc Previsione

Obiettivo di Prezzo

Consenso sulla valutazione

Punteggio Tecnico

Notizie finanziarie

Altri titoli del settore